SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.010.0%2:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Dunlap who wrote (3828)6/30/1998 11:13:00 PM
From: VLAD  Read Replies (1) of 9523
 
Don,

Pfizer will be sued it is just a question of how many more weeks will pass before a class action announcement is made. Viagra was given fast track approval on a study of about 2,000 men who were able to have intercourse at least once in the month prior to entering the study. Men taking Viagra now are much more impotent and have more severe underlying health problems. Studies were not conducted with Viagra and concurrent use of all common high blood pressure medications. Concurrent use with Glucotrol is also now in question. The retinopathy issue also remains to be studied--the outcome I suspect will be to the detriment of Viagra.

Again, I do not wish to see the PFE shareholder lose value. I just warn of the repercussions of Viagra.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext